Medicine & Life Sciences
Prostatic Neoplasms
100%
Castration
77%
Immunotherapy
70%
Neoplasms
60%
sipuleucel-T
45%
Renal Cell Carcinoma
42%
Natural Killer Cells
42%
Leukocytes
38%
T-Lymphocytes
36%
Urinary Bladder Neoplasms
34%
Tumor Microenvironment
33%
Cell Adhesion Molecule-1
32%
Nivolumab
31%
Integrins
31%
Multiparametric Magnetic Resonance Imaging
30%
Anti-Idiotypic Antibodies
27%
Survival
26%
Antigens
26%
Therapeutics
23%
Chemotactic Factors
22%
TRC105
21%
Ipilimumab
21%
Melanoma
21%
Radiotherapy
21%
Proteomics
20%
Carcinoma
18%
Safety
18%
Chemokine CCL21
17%
cabozantinib
17%
Lymphocytes
17%
Axitinib
17%
Drug Therapy
17%
Central Tolerance
16%
pazopanib
16%
Neoplasm Metastasis
16%
Docetaxel
15%
Chemokines
15%
Melanoma-Specific Antigens
15%
Dendritic Cells
15%
Histology
14%
Interleukin-7
14%
Cell-Free Nucleic Acids
13%
tazarotene
13%
antineoplaston A10
13%
Clinical Trials, Phase I
13%
Muscles
13%
Radiopharmaceuticals
13%
Progression-Free Survival
13%
Listeria monocytogenes
12%
Watchful Waiting
12%